The T1D Exchange Registry
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- T1D Exchange, United States
- Study ID
- NCT04629586
- Status
- Recruiting
Conditions
- Diabetes
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Type 1 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- No intervention — OTHERObservational research study
Study Details
The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes. To participate, you will be asked to: * Read and sign an online informed consent form * Take a survey describing specific demographic and type 1 diabetes management information * Update your information annually * Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data
Key Dates
- Start date
- Dec 13, 2018
- Status verified
- May 2023
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 50,000 participants (estimated)
Arms
- Arm: Individuals diagnosed with type 1 diabetesT1D Exchange Registry is currently looking for participants: * Of all ages, genders, races, and ethnic groups * Living in the United States * Diagnosed with type 1 diabetes * Currently taking insulin or have had a pancreatic or islet cell transplant
Primary Outcome Measure
Gather longitudinal data from individuals living with type 1 diabetes. [ Time Frame: 10 years ]
Central Contacts
- Kelsie LaFerrier(617) 892-9941
- Julia Ravelson(617) 892-9941
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| T1D Exchange | Boston | Massachusetts | 02111 |
Find similar trials in Boston, MA
Related Studies
- TrialNet Pathway to Prevention of T1DRecruiting · University of South Florida · Orange, California
- Imaging Histone Deacetylase in the HeartRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Personalized Responses to Dietary Composition Trial 3Recruiting · Zoe Global Limited · Needham, Massachusetts
- A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 DiabetesPHASE3 · Recruiting · Vertex Pharmaceuticals Incorporated · Duarte, California